China Biopharmaceutical Limited Unveils New Global Brand SBP Group, Accelerates International Expansion

China Biopharmaceutical Limited, a leading innovation-driven pharmaceutical company in China, announced the launch of its new global brand, SBP Group, during its mid-term performance release event. The acronym SBP stands for Science, Breakthroughs, and Patients, symbolizing the company’s focus on science, innovation breakthroughs, and global patient welfare. This ethos aligns with the company’s mission of “health technology, warming more lives.” The unified brand image reflects the company’s strategic evolution from a leading domestic biopharmaceutical company to a global innovator. The transformation is advancing on two fronts simultaneously: globalizing products through a mix of self-innovation, business development, and mergers and acquisitions…